Canada Goose Q4 Beats, but FY2027 Guidance Signals Margin Challenges Ahead

What happened

Canada Goose reported a strong Q4 FY2026 with revenue growth of 17.9% YoY, beating expectations. However, the company issued mixed FY2027 guidance projecting low single-digit revenue growth with EBIT margin improving to 11–12%, reflecting ongoing profitability repair. The DeepValue report maintains a WAIT rating, noting that while Q3 showed DTC comparable sales +6.3%, adjusted EBIT margin contracted due to SG&A deleverage from marketing and store investments. The report highlights that the current valuation of ~$12.20 offers no margin of safety, with a P/E of 75x and net debt/EBITDA of nearly 2x, and the key question is whether SG&A growth can slow while revenue sustains. Patient investors await observable operating leverage, with attractive entry at $10.50 and re-assessment in 3–6 months.

Implication

Investors should wait for concrete evidence of operating leverage, specifically positive DTC comparable sales and stabilization of adjusted EBIT margin around 29–30%. The DeepValue report sets an attractive entry at $10.50, implying a 14% downside from current levels, and suggests trimming above $14.50. Near-term catalysts include Q4 FY2026 results confirming sustained demand and management providing explicit efficiency targets. Key risks include renewed negative DTC comps or further SG&A deleverage, which could pressure the stock to the bear case of $9.00. The investment thesis hinges on the next two quarters showing that marketing spend is converting into durable revenue without margin compression.

Thesis delta

The Q4 beat confirms demand strength, but FY2027 guidance pushes EBIT margin recovery further out, reinforcing the WAIT stance. The thesis shifts from 'when will margins recover' to 'can margins recover without sacrificing growth' as management signals continued investment. Investors should focus on the pace of SG&A leverage rather than revenue beats.